Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase II Study to Evaluate the Impact on Biomarkers of Resveratrol Treatment in Patients With Mild to Moderate Alzheimer's Disease

NCT01504854 is registered in ClinicalTrials.gov with Alzheimer's Disease Cooperative Study (ADCS) as lead sponsor.

NCT NCT01504854
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01504854 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase II Study to Evaluate the Impact on Biomarkers of Resveratrol Treatment in Patients With Mild to Moderate Alzheimer's Disease
Lead sponsor
Alzheimer's Disease Cooperative Study (ADCS)
Phase
Phase 2
Overall status
Completed
Start date
May 31, 2012
Completion date
March 31, 2014
Enrollment
119 (actual)
Sites
26

Conditions

As the registry lists them; a condition with its own page is linked.

alzheimer's disease